HIV and aging: Effects on the central nervous system

Seminars in Neurology

Volumn 34, Issue 1, 2014, Pages 27-34

  Cañizares, Silvia ^a   Cherner, Mariana ^b   Ellis, Ronald J ^c  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aging; human immunodeficiency virus; metabolic syndrome; neurocognitive; neuroimaging

Indexed keywords

AGING; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR RISK; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DIFFUSION TENSOR IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLIC DISORDER; METABOLIC SYNDROME X; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; CENTRAL NERVOUS SYSTEM DISEASES; COMPLICATION; VIROLOGY;

AGING; CENTRAL NERVOUS SYSTEM DISEASES; HIV INFECTIONS; HUMANS;

EID: 84898447714     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0034-1372340     Document Type: Article

References (71)

1. Bhaskaran K., Mussini C., Antinori A., et al. CASCADE Collaboration. Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol: 2008; 63 2 213 221 (Pubitemid 351355300)
2. Brew B. J., Letendre S. L. Biomarkers of HIV related central nervous system disease. Int Rev Psychiatry: 2008; 20 1 73 88 (Pubitemid 351196203)
3. McArthur J. C., Brew B. J. HIV-associated neurocognitive disorders: is there a hidden epidemic? AIDS: 2010; 24 9 1367 1370
4. Soontornniyomkij V., Achim C. Aging. In: Gendelman H. E., Grant I., Everall P. E., et al, eds. The neurology of AIDS. 3rd edition. New York Oxford Univeristy Press: 2012; 567 580
5. Rodriguez-Penney A. T., Iudicello J. E., Riggs P. K., et al. HIV Neurobehavioral Research Program HNRP Group. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDS: 2013; 27 1 5 16
6. Green D. A., Masliah E., Vinters H. V., Beizai P., Moore D. J., Achim C. L. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS: 2005; 19 4 407 411 (Pubitemid 40446187)
7. Khanlou N., Moore D. J., Chana G., et al. HNRC Group. Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neurovirol: 2009; 15 2 131 138
8. Worm S. W., Lundgren J. D. The metabolic syndrome in HIV. Best Pract Res Clin Endocrinol Metab: 2011; 25 3 479 486
9. Ciccarelli N., Fabbiani M., Di Giambenedetto S., et al. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology: 2011; 76 16 1403 1409
10. Schweinsburg B. C., Taylor M. J., Alhassoon O. M., et al. HNRC Group. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol: 2005; 11 4 356 364 (Pubitemid 41614515)
11. Liner J., Meeker R. B., Robertson K. CNS toxicity of antiretroviral drugs. Paper presented at: 17th Conference on Retroviruses and Opportunistic Infections; February 16-19, 2010: San Francisco, CA.
12. Heaton R. K., Clifford D. B., Franklin D. R. Jr., et al. CHARTER Group. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology: 2010; 75 23 2087 2096
13. Antinori A., Arendt G., Becker J. T., et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology: 2007; 69 18 1789 1799 (Pubitemid 350059308)
14. Mind Exchange Working Group Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis: 2013; 56 7 1004 1017
15. Bhatia R., Ryscavage P., Taiwo B. Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy. J Neurovirol: 2012; 18 4 247 255
16. Hardy D. J., Vance D. E. The neuropsychology of HIV/AIDS in older adults. Neuropsychol Rev: 2009; 19 2 263 272
17. Valcour V., Shikuma C., Shiramizu B., et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology: 2004; 63 5 822 827 (Pubitemid 39297641)
18. Becker J. T., Lopez O. L., Dew M. A., Aizenstein H. J. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS: 2004; 18 01 S11 S18 (Pubitemid 38365901)
19. Cherner M., Ellis R. J., Lazzaretto D., et al. HIV Neurobehavioral Research Center Group. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS: 2004; 18 01 S27 S34 (Pubitemid 38365903)
20. Morgan E. E., Iudicello J. E., Weber E., et al. HIV Neurobehavioral Research Program (HNRP) Group. Synergistic effects of HIV infection and older age on daily functioning. J Acquir Immune Defic Syndr: 2012; 61 3 341 348
21. MacDonald S. W., Hultsch D. F., Dixon R. A. Performance variability is related to change in cognition: evidence from the Victoria Longitudinal Study. Psychol Aging: 2003; 18 3 510 523 (Pubitemid 37152068)
22. Morgan E. E., Woods S. P., Delano-Wood L., Bondi M. W., Grant I.; HIV Neurobehavioral Research Program (HNRP) Group. Intraindividual variability in HIV infection: evidence for greater neurocognitive dispersion in older HIV seropositive adults. Neuropsychology: 2011; 25 5 645 654
23. van Gorp W. G., Miller E. N., Marcotte T. D., et al. The relationship between age and cognitive impairment in HIV-1 infection: findings from the Multicenter AIDS Cohort Study and a clinical cohort. Neurology: 1994; 44 5 929 935 (Pubitemid 24158812)
24. Vance D. E., Wadley V. G., Crowe M. G., Raper J. L., Ball K. K. Cognitive and everyday functioning in older and younger adults with and without HIV. Clin Gerontol: 2011; 34 5 413 426
25. Sacktor N., Skolasky R. L., Cox C., et al. Multicenter AIDS Cohort Study (MACS). Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus. J Neurovirol: 2010; 16 5 335 341
26. Cysique L. A., Maruff P., Bain M. P., Wright E., Brew B. J. HIV and age do not substantially interact in HIV-associated neurocognitive impairment. J Neuropsychiatry Clin Neurosci: 2011; 23 1 83 89
27. Wilkie F. L., Goodkin K., Khamis I., et al. Cognitive functioning in younger and older HIV-1-infected adults. J Acquir Immune Defic Syndr: 2003; 33 02 S93 S105 (Pubitemid 36801607)
28. Onen N. F., Overton E. T., Seyfried W., et al. Aging and HIV infection: a comparison between older HIV-infected persons and the general population. HIV Clin Trials: 2010; 11 2 100 109
29. Valcour V., Paul R., Neuhaus J., Shikuma C. The effects of age and HIV on neuropsychological performance. J Int Neuropsychol Soc: 2011; 17 1 190 195
30. Becker J. T., Maruca V., Kingsley L. A., et al. Multicenter AIDS Cohort Study. Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology: 2012; 54 2 113 121
31. Towgood K. J., Pitkanen M., Kulasegaram R., et al. Mapping the brain in younger and older asymptomatic HIV-1 men: frontal volume changes in the absence of other cortical or diffusion tensor abnormalities. Cortex: 2012; 48 2 230 241
32. Ances B. M., Ortega M., Vaida F., Heaps J., Paul R. Independent effects of HIV, aging, and HAART on brain volumetric measures. J Acquir Immune Defic Syndr: 2012; 59 5 469 477
33. Pfefferbaum A., Rosenbloom M. J., Sassoon S. A., et al. Regional brain structural dysmorphology in human immunodeficiency virus infection: effects of acquired immune deficiency syndrome, alcoholism, and age. Biol Psychiatry: 2012; 72 5 361 370
34. Stout J. C., Ellis R. J., Jernigan T. L., et al. HIV Neurobehavioral Research Center Group. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. Arch Neurol: 1998; 55 2 161 168
35. Chang L., Andres M., Sadino J., et al. Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging. Neuroimage: 2011; 58 4 1017 1027
36. Chen Y., An H., Zhu H., et al. White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients. Neuroimage: 2009; 47 4 1154 1162
37. Chang L., Wong V., Nakama H., et al. Greater than age-related changes in brain diffusion of HIV patients after 1 year. J Neuroimmune Pharmacol: 2008; 3 4 265 274
38. Gongvatana A., Cohen R. A., Correia S., et al. Clinical contributors to cerebral white matter integrity in HIV-infected individuals. J Neurovirol: 2011; 17 5 477 486
39. Chang L., Ernst T., Leonido-Yee M., et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology: 1999; 53 4 782 789 (Pubitemid 29448300)
40. Holt J. L., Kraft-Terry S. D., Chang L. Neuroimaging studies of the aging HIV-1-infected brain. J Neurovirol: 2012; 18 4 291 302
41. Chang L., Lee P. L., Yiannoutsos C. T., et al. HIV MRS Consortium. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage: 2004; 23 4 1336 1347 (Pubitemid 40260357)
42. Harezlak J., Buchthal S., Taylor M., et al. HIV Neuroimaging Consortium. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS: 2011; 25 5 625 633
43. Cysique L. A., Moffat K., Moore D. M., et al. HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study. PLoS ONE: 2013; 8 4 e61738
44. Ernst T., Jiang C. S., Nakama H., Buchthal S., Chang L. Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder. J Magn Reson Imaging: 2010; 32 5 1045 1053
45. Orringer D. A., Vago D. R., Golby A. J. Clinical applications and future directions of functional MRI. Semin Neurol: 2012; 32 4 466 475
46. Thomas J. B., Brier M. R., Snyder A. Z., Vaida F. F., Ances B. M. Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity. Neurology: 2013; 80 13 1186 1193
47. Ances B. M., Vaida F., Yeh M. J., et al. HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. J Infect Dis: 2010; 201 3 336 340
48. Ernst T., Yakupov R., Nakama H., et al. Declined neural efficiency in cognitively stable human immunodeficiency virus patients. Ann Neurol: 2009; 65 3 316 325
49. Chang L., Holt J. L., Yakupov R., Jiang C. S., Ernst T. Lower cognitive reserve in the aging human immunodeficiency virus-infected brain. Neurobiol Aging: 2013; 34 4 1240 1253
50. Krishnan S., Schouten J. T., Atkinson B., et al. Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals. J Acquir Immune Defic Syndr: 2012; 61 3 381 389
51. Boden-Albala B., Sacco R. L., Lee H. S., et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke: 2008; 39 1 30 35
52. Valcour V. G., Sacktor N. C., Paul R. H., et al. Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging with HIV cohort. J Acquir Immune Defic Syndr: 2006; 43 4 405 410 (Pubitemid 44737096)
53. Valcour V. G., Shikuma C. M., Shiramizu B. T., et al. Diabetes, insulin resistance, and dementia among HIV-1-infected patients. J Acquir Immune Defic Syndr: 2005; 38 1 31 36 (Pubitemid 40094115)
54. McCutchan J. A., Marquie-Beck J. A., Fitzsimons C. A., et al. CHARTER Group. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology: 2012; 78 7 485 492
55. Nakamoto B. K., Jahanshad N., McMurtray A., et al. Cerebrovascular risk factors and brain microstructural abnormalities on diffusion tensor images in HIV-infected individuals. J Neurovirol: 2012; 18 4 303 312
56. Brew B. J., Crowe S. M., Landay A., Cysique L. A., Guillemin G. Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol: 2009; 4 2 163 174
57. Rempel H. C., Pulliam L. HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS: 2005; 19 2 127 135 (Pubitemid 40409531)
58. Brew B. J., Pemberton L., Blennow K., Wallin A., Hagberg L. CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology: 2005; 65 9 1490 1492 (Pubitemid 41552790)
59. Clifford D. B., Fagan A. M., Holtzman D. M., et al. CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology: 2009; 73 23 1982 1987
60. Gisslén M., Krut J., Andreasson U., et al. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol: 2009; 9 63
61. Ances B. M., Christensen J. J., Teshome M., et al. Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study. Neurology: 2010; 75 2 111 115
62. Ances B. M., Benzinger T. L., Christensen J. J., et al. 11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder. Arch Neurol: 2012; 69 1 72 77
63. Valcour V. G. HIV, aging, and cognition: emerging issues. Top Antivir Med: 2013; 21 3 119 123
64. Jahanshad N., Valcour V. G., Nir T. M., et al. Disrupted brain networks in the aging HIV+ population. Brain Connect: 2012; 2 6 335 344
65. Morgan E. E., Woods S. P., Letendre S. L., et al. CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol: 2013; 19 2 150 156
66. Kuhlmann I., Minihane A. M., Huebbe P., Nebel A., Rimbach G. Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review. Lipids Health Dis: 2010; 9 8
67. Wendelken L. A., Valcour V. Impact of HIV and aging on neuropsychological function. J Neurovirol: 2012; 18 4 256 263
68. Becker J. T., Kingsley L., Mullen J., et al. Multicenter AIDS Cohort Study. Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology: 2009; 73 16 1292 1299
69. Wright E. J., Grund B., Robertson K., et al. INSIGHT SMART Study Group. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology: 2010; 75 10 864 873
70. Foley J., Ettenhofer M., Wright M. J., et al. Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age. Clin Neuropsychol: 2010; 24 2 265 285
71. Fabbiani M., Ciccarelli N., Tana M., et al. Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med: 2013; 14 3 136 144